Press release
Inhaled Nitric Oxide Market: A Breath of Innovation in Respiratory Care
Inhaled Nitric Oxide Market
The global inhaled nitric oxide (iNO) market is experiencing significant growth, driven by increasing neonatal respiratory disorders, rising cases of pulmonary diseases, and advancements in healthcare infrastructure. Valued at $0.8 billion in 2022, the market is projected to reach $1.6 billion by 2032, expanding at a robust CAGR of 7.7% from 2023 to 2032.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/3020
Why is Inhaled Nitric Oxide Gaining Traction?
Inhaled nitric oxide is a selective pulmonary vasodilator used to treat conditions such as persistent pulmonary hypertension in newborns (PPHN), acute respiratory distress syndrome (ARDS), and chronic obstructive pulmonary disease (COPD). Its effectiveness in improving oxygenation without systemic side effects makes it a preferred therapeutic option in critical care settings.
Key Market Drivers
Rising Preterm Births: Preterm births account for 5-18% of global births, leading to increased demand for iNO therapy in managing respiratory distress syndrome (RDS).
Growing Respiratory Disorders: A surge in conditions like COPD, asthma, and ARDS, exacerbated by pollution and an aging population, is propelling market demand.
Regulatory Approvals & Expanding Applications: The FDA's approval of iNO for neonatal hypoxic respiratory failure has solidified its role in clinical care.
Improved Healthcare Infrastructure: The adoption of advanced iNO delivery systems is increasing in modern healthcare facilities, enhancing treatment accessibility.
Market Segmentation & Trends
By Application:
Neonatal Respiratory Treatment (Dominant segment, due to widespread use in PPHN and RDS)
COPD Management
ARDS Treatment
Other Pulmonary Conditions
By Region:
North America - Largest market, supported by advanced healthcare facilities and strong R&D investment.
Europe - Steady growth due to regulatory support and increasing cases of respiratory diseases.
Asia-Pacific - Fastest-growing region, driven by rising healthcare investments and increasing respiratory disorders.
LAMEA - Gradual adoption with untapped potential in developing regions.
Challenges & Opportunities
Barriers to Growth:
High Treatment Costs: iNO therapy involves complex production and specialized delivery systems, limiting access in lower-income regions.
Future Opportunities:
Expanding R&D: Ongoing research into new therapeutic applications, such as COVID-19-related respiratory failure, could unlock new growth avenues.
Technological Advancements: Innovations in portable iNO delivery devices could enhance convenience and broaden adoption.
Competitive Landscape
Major players in the market include:
Air Liquide
Linde PLC
Mallinckrodt Pharmaceuticals
Vero Biotech
These companies are investing in patents, clinical trials, and strategic partnerships to strengthen their market position.
Recent Developments
Linde PLC (2020): Won a nitric oxide patent case and supplied iNO for COVID-19-related respiratory studies.
SOL Group (2021): Expanded its footprint in India by increasing its stake in SICGILSOL, a pioneer in iNO therapy in the region.
Final Thoughts
The inhaled nitric oxide market is set for significant expansion, fueled by increasing neonatal and adult respiratory disorders, coupled with continuous advancements in medical technologies. Despite the challenge of high costs, growing research efforts and infrastructure improvements will drive further adoption.
🚀 Key Takeaway: North America leads the market, while Asia-Pacific is emerging as a high-growth region, making iNO a critical component of future respiratory care. The next decade promises transformative advancements in this field.
Enquire Before Buying: https://www.alliedmarketresearch.com/purchase-enquiry/3020
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland Oregon. AMR provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients in making strategic business decisions and achieving sustainable growth in their respective market domains.
AMR launched its user-based online library of reports and company profiles Avenue. An e-access library is accessible from any device anywhere and at any time for entrepreneur's stakeholder's researchers and students at universities. With reports on more than 60000 niche markets with data comprising of 600000 pages along with company profiles on more than 12000 firms, Avenue offers access to the entire repository of information through subscriptions. A hassle-free solution to clients' requirements is complemented with analyst support and customization requests.
Contact:
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Int'l: +1-503-894-6022
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
India (Pune): +91-20-66346060
Fax: +1-800-792-5285
help@alliedmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Inhaled Nitric Oxide Market: A Breath of Innovation in Respiratory Care here
News-ID: 3949569 • Views: …
More Releases from Allied Market Research
Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529
What Are Urinary Drainage Bags?
Urinary drainage bags are specialized medical devices designed to collect…
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031.
The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growth…
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil …
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario.
Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strict…
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of …
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031.
Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise in…
More Releases for Inhaled
Devices for Inhaled Medications Market Size 2024 to 2031.
Market Overview and Report Coverage
Devices for inhaled medications are medical devices that deliver medication directly into the lungs through inhalation, predominantly used for treating respiratory conditions such as asthma, chronic obstructive pulmonary disease, and cystic fibrosis. These devices are essential for patients who require immediate relief or long-term management of their respiratory conditions.
The future outlook of the Devices for Inhaled Medications Market looks promising, with a projected growth…
Inhaled Antibiotics Market Size, Insights, Analysis Report 2024-2033
The inhaled antibiotics market size has grown strongly in recent years. It will grow from $1.46 billion in 2023 to $1.58 billion in 2024 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to regulatory support and approvals, shift from systemic to targeted delivery, rise in antibiotic resistance, increase in respiratory infections.
The inhaled antibiotics market size is expected to…
Inhaled Nitric Oxide Market Driving Extraordinary Expansion and Profitable Growt …
Astute Analytica has conducted an in-depth research study on the inhaled nitric oxide market, providing a detailed analysis that considers crucial elements such as market size, industry share, and key competitors.
The global inhaled nitric oxide market is projected to reach a value of US$ 426.88 million by 2031. In 2022, the market was valued at US$ 246.07 million and is anticipated to grow at a CAGR of 6.64% during the…
Inhaled NO Vasodilator Market: Competitive Dynamics & Global Outlook 2020-2025
Global Info Research offers a latest published report on Inhaled NO Vasodilator Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Inhaled NO Vasodilator Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
Click to view the full report TOC, figure…
Inhaled Antibiotics Market to Surpass US$ 1,784.9 Mn by 2027
Global Inhaled Antibiotics Market, by Product Type (Aerosol, Dry Powder Formulation, and Spray), by Application (Pneumonia, Asthma, Bronchitis, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 1,160.69 million in 2020 and is projected to exhibit a CAGR of 6.3% over the forecast period (2020–2027), as…
Global Inhaled Antibiotics Market Huge Growth Opportunity between 2020-2025
LP INFORMATION recently released a research report on the Inhaled Antibiotics market analysis and elaborate the industry coverage, current market competitive status, and market outlook and forecast by 2025. Moreover, it categorizes the global Inhaled Antibiotics market by key players, product type, applications and regions,etc.
The main objective of this market research is to help the readers understand the structure of Inhaled Antibiotics market, market definition, overview, industry opportunities and…
